Patents by Inventor Brian R. Wong

Brian R. Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
    Publication number: 20240101533
    Abstract: The present disclosure relates to methods and intermediates useful for preparing a compound of formula I: or a co-crystal, solvate, salt or combination thereof.
    Type: Application
    Filed: June 5, 2023
    Publication date: March 28, 2024
    Inventors: Kevin McCormack Allan, Amanda Lynn Vandehey, Gediminas Brizgys, Sachin Dhar, Ian James Doxsee, Alex Goldberg, Lars V. Heumann, Zilin Huang, Nathaniel Thomas Kadunce, Shahrokh Kazerani, Willard Lew, Vinh Xuan Ngo, Brian Michael O`Keefe, Trevor James Rainey, Benjamin James Roberts, Bing Shi, Dietrich P. Steinhuebel, Winston C. Tse, Anna Michelle Wagner, Xianghong Wang, Scott Alan Wolckenhauer, Chloe Yuyi Wong, Jennifer R. Zhang
  • Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
    Patent number: 7371537
    Abstract: The present invention provides compositions and methods for modulating B-lymphocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating B-lymphocyte activation are provided. Compositions and methods for the treatment of disorders related to dysfunction or dysregulation of B-lymphocyte activation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating B-lymphocyte activation.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: May 13, 2008
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Marcy K. Vallone, Brian R. Wong, Esteban Masuda, Mark Powell
  • Modulators of leukocyte activation, Hck compositions and methods of use
    Patent number: 7067266
    Abstract: The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: June 27, 2006
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Annabelle Friera, Brian R. Wong, Esteban Masuda, Mark Powell
  • Modulators of leukocyte activation, BIC compositions and methods of use
    Patent number: 6929923
    Abstract: The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: August 16, 2005
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Marcy K. Vallone, Brian R. Wong, Esteban Masuda, Mark Powell
  • Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
    Patent number: 6890725
    Abstract: The present invention provides compositions and methods for modulating B-lymphocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating B-lymphocyte activation are provided. Compositions and methods for the treatment of disorders related to dysfunction or dysregulation of B-lymphocyte activation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating B-lymphocyte activation.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: May 10, 2005
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Marcy K. Vallone, Brian R. Wong, Esteban Masuda, Mark Powell
  • Modulators of leukocyte activation, BIC compositions and methods of use
    Publication number: 20040018566
    Abstract: The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
    Type: Application
    Filed: July 23, 2002
    Publication date: January 29, 2004
    Inventors: Marcy K. Vallone, Brian R. Wong, Esteban Masuda, Mark Powell
  • Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
    Publication number: 20040018567
    Abstract: The present invention provides compositions and methods for modulating B-lymphocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating B-lymphocyte activation are provided. Compositions and methods for the treatment of disorders related to dysfunction or dysregulation of B-lymphocyte activation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating B-lymphocyte activation.
    Type: Application
    Filed: July 23, 2002
    Publication date: January 29, 2004
    Inventors: Marcy K. Vallone, Brian R. Wong, Esteban Masuda, Mark Powell
  • Modulators of leukocyte activation, Hck compositions and methods of use
    Publication number: 20040009173
    Abstract: The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
    Type: Application
    Filed: July 10, 2002
    Publication date: January 15, 2004
    Inventors: Annabelle Friera, Brian R. Wong, Esteban Masuda, Mark Powell